Immunogenicity Reduction

Immunogenicity Reduction is a therapeutic antibody engineering and design strategy that systematically modifies antibody sequences, structures, or formulations to decrease their propensity to elicit undesired immune responses, such as anti-drug antibodies, while maintaining their intended biological function and clinical efficacy.

179

Publications

9.4K

Citations

1K

Authors

331

Institutions

Publications per year

2017–2026

35

Authors

1K

  1. BB
    Baruj Benacerraf

    Harvard University, United States

    5 publications · 480 citations

    5

    h-index

  2. SJ
    Shaoyi Jiang

    University of Washington, United States

    4 publications · 452 citations

    4

    h-index

  3. CT
    Caroline Tsao

    University of Washington, United States

    4 publications · 432 citations

    4

    h-index

  4. CR
    Christopher R. Parish

    Australian National University, Australia

    4 publications · 507 citations

    4

    h-index

  5. DH
    David H. Katz

    Harvard University, United States

    4 publications · 467 citations

    4

    h-index

1–5 of 1K

Venues

  1. PubMed

    Repository · 12 publications · 407 citations

    11

    h-index

  2. The Journal of Immunology

    JI · 10 publications · 596 citations

    10

    h-index

  3. Journal of Immunological Methods

    9 publications · 340 citations

    9

    h-index

  4. The Journal of Experimental Medicine

    5 publications · 903 citations

    5

    h-index

  5. Vaccine

    5 publications · 191 citations

    5

    h-index

1–5